# Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)

> **NCT01208909** · — · UNKNOWN · sponsor: **University of Zurich** · enrollment: 40 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** diagnostic 5-ALA and MRI for tumor resection

## Key facts

- **NCT ID:** NCT01208909
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01208909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01208909, "Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01208909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*